Close
Back to mobile site

Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's (BMY) Ill-Advised Proposed Acquisition of Celgene (CELG)

March 19, 2019 7:04 AM EDT Send to a Friend
Starboard Value LP (together with its affiliates, "Starboard"), a stockholder of Bristol-Myers Squibb Company ("Bristol-Myers" or the "Company")(NYSE: BMY) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login